<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02094612</url>
  </required_header>
  <id_info>
    <org_study_id>CN-13-1692-H</org_study_id>
    <secondary_id>Quotient ADHD</secondary_id>
    <nct_id>NCT02094612</nct_id>
  </id_info>
  <brief_title>Effectiveness of the Quotient® ADHD Assessment in a System of Care</brief_title>
  <official_title>Effectiveness of the Quotient® ADHD Assessment in a System of Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pearson/Clinical Assessment</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaiser Permanente</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study goal is to examine whether the use of an objective computerized neuroassessment
      (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to
      improved outcomes among pediatric patients being assessed and treated for ADHD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, controlled trial using a 2-phase data collection. The first phase
      is the initial assessment for ADHD and includes all patients eligible to be assessed for ADHD
      as determined by their clinician in the course of usual care. The baseline measurements will
      be used to compare groups at baseline, and also for longitudinal analyses of medication
      management. Patients are randomized at this point. Patients in both treatment arms who then
      receive an ADHD diagnosis and who start medication for ADHD will be eligible for the second
      phase of the study: three follow-up assessments over six months. Patients who do not have an
      ADHD diagnosis will not continue in the study, and will be treated by their clinician as
      usual.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">August 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With 25% Reduction in SNAP Scores</measure>
    <time_frame>One month, 3 month and six month follow ups</time_frame>
    <description>Outcome measure reported is the number of participants with at least one 25% reduction in SNAP between visits. In treatment of ADHD, the therapeutic dose is defined as a 25% reduction in SNAP IV score between consecutive clinic visits. SNAP is itemized rating scale (Swanson, Nolan, and Pelham-IV Questionnaire) designed to measure ADHD symptoms and severity on a 4 point scale. It is based on DSM IV criteria, and is designed to measure attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in children and young adults ages 6-18.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ADHD Symptomatology</measure>
    <time_frame>6 months post baseline</time_frame>
    <description>Outcomes reported are average SNAP IV scores at baseline and 6 monhts. ADHD symptomatology is measured by the Swanson, Nolan and Pelham Teacher and Parent Rating Scale (SNAP-IV), developed by James Swanson, Edith Nolan and William Pelham. We used the 18-item self-report inventory designed to measure attention deficit hyperactivity disorder (ADHD) symptoms in children and young adults. Each question measures the frequency of a variety of symptoms or behaviors.The subscales measure Inattention (9 items) and Hyperactivity/impulsivity (9 items), using 0-3 rating, 0=&quot;not at all&quot;, 1=&quot;just a little&quot;, 2=&quot;quite a bit&quot;, or 3=&quot;very much. Each 9-item subscale results in a score in range 0-27. The two subscale scores were averaged to create a single score for the 18-item SNAP.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Academic Performance</measure>
    <time_frame>Baseline and Six Months</time_frame>
    <description>Academic performance will be measured by student report cards, and converted to a standardized scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistence in Care</measure>
    <time_frame>Baseline to Six Months</time_frame>
    <description>Update: Outcome measure reported is the # of participants who attended all study follow-up visits.
Use of pediatric health care services</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication Adherence</measure>
    <time_frame>Baseline to six months</time_frame>
    <description>Update: Outcome reported is number of participants taking medication as prescribed at all study follow up visits.
Sustained use of ADHD medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction With Care</measure>
    <time_frame>Six months</time_frame>
    <description>Update: Outcome measure reported is number of participants who responded &quot;very satisfied&quot; with their ADHD care on 5-point Likert scale.
Likert scale single item measure of how satisfied the pediatric patient's parent was with care received</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other Health Services Use</measure>
    <time_frame>Baseline to six months</time_frame>
    <description>Update: Outcome measure reported is number of psychiatric and ED visits during the 6 month follow up period.
Use of healthcare services outside of pediatrics, including the emergency room and psychiatric services.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">207</enrollment>
  <condition>Attention Deficit and Disruptive Behavior Disorders</condition>
  <condition>Attention Deficit Disorder With Hyperactivity</condition>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Usual clinic ADHD care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care plus Assessment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Usual clinic ADHD care plus the Quotient®</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Quotient®</intervention_name>
    <description>Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
    <arm_group_label>Usual Care plus Assessment</arm_group_label>
    <other_name>OpTAX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Usual Clinic ADHD Care</intervention_name>
    <description>Usual ADHD care as provided by the clinic</description>
    <arm_group_label>Usual Care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients within the specified age range who are English speaking and who are
             presenting for ADHD assessment are eligible. An additional criterion is consent to be
             randomized.

        Exclusion Criteria:

          -  Non English speaking

          -  Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia I Campbell, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kaiser Permanente</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaiser Permanente, Folsom</name>
      <address>
        <city>Folsom</city>
        <state>California</state>
        <zip>95630</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente, Roseville</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente, Walnut Creek Medical Center</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94596</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chinchilli VM, Fisher L, Craig TJ. Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge. J Allergy Clin Immunol. 2005 Mar;115(3):592-7.</citation>
    <PMID>15753909</PMID>
  </reference>
  <reference>
    <citation>Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000 May;105(5):1158-70. Review.</citation>
    <PMID>10836893</PMID>
  </reference>
  <reference>
    <citation>Foy JM, Earls MF. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Pediatrics. 2005 Jan;115(1):e97-104.</citation>
    <PMID>15629972</PMID>
  </reference>
  <reference>
    <citation>Herrerias CT, Perrin JM, Stein MT. The child with ADHD: using the AAP Clinical Practice Guideline. American Academy of Pediatrics. Am Fam Physician. 2001 May 1;63(9):1803-10.</citation>
    <PMID>11352293</PMID>
  </reference>
  <reference>
    <citation>Jensen PS, Garcia JA, Glied S, Crowe M, Foster M, Schlander M, Hinshaw S, Vitiello B, Arnold LE, Elliott G, Hechtman L, Newcorn JH, Pelham WE, Swanson J, Wells K. Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD. Am J Psychiatry. 2005 Sep;162(9):1628-36.</citation>
    <PMID>16135621</PMID>
  </reference>
  <reference>
    <citation>Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics. 1986 Sep;42(3):507-19.</citation>
    <PMID>3567285</PMID>
  </reference>
  <reference>
    <citation>Langberg JM, Froehlich TE, Loren RE, Martin JE, Epstein JN. Assessing children with ADHD in primary care settings. Expert Rev Neurother. 2008 Apr;8(4):627-41. doi: 10.1586/14737175.8.4.627. Review.</citation>
    <PMID>18416664</PMID>
  </reference>
  <reference>
    <citation>Leslie LK, Weckerly J, Plemmons D, Landsverk J, Eastman S. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics. 2004 Jul;114(1):129-40.</citation>
    <PMID>15231919</PMID>
  </reference>
  <reference>
    <citation>Leslie LK, Wolraich ML. ADHD service use patterns in youth. J Pediatr Psychol. 2007 Jul;32(6):695-710. Epub 2007 Jun 7. Review.</citation>
    <PMID>17556401</PMID>
  </reference>
  <reference>
    <citation>Shaw M, Hodgkins P, Caci H, Young S, Kahle J, Woods AG, Arnold LE. A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Med. 2012 Sep 4;10:99. doi: 10.1186/1741-7015-10-99. Review.</citation>
    <PMID>22947230</PMID>
  </reference>
  <reference>
    <citation>Pelham WE, Foster EM, Robb JA. The economic impact of attention-deficit/hyperactivity disorder in children and adolescents. J Pediatr Psychol. 2007 Jul;32(6):711-27. Epub 2007 Jun 7. Review.</citation>
    <PMID>17556402</PMID>
  </reference>
  <reference>
    <citation>Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983 Jun;39(2):499-503.</citation>
    <PMID>6354290</PMID>
  </reference>
  <reference>
    <citation>Xie H, McHugo G, Drake R, Sengupta A. Using discrete-time survival analysis to examine patterns of remission from substance use disorder among persons with severe mental illness. Ment Health Serv Res. 2003 Mar;5(1):55-64.</citation>
    <PMID>12602646</PMID>
  </reference>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 13, 2014</study_first_submitted>
  <study_first_submitted_qc>March 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2014</study_first_posted>
  <results_first_submitted>January 31, 2017</results_first_submitted>
  <results_first_submitted_qc>June 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">July 17, 2017</results_first_posted>
  <last_update_submitted>June 19, 2017</last_update_submitted>
  <last_update_submitted_qc>June 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Attention Deficit and Disruptive Behavior Disorders</keyword>
  <keyword>Attention Deficit Disorder with Hyperactivity</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Patient Outcome Assessment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
    <mesh_term>Hyperkinesis</mesh_term>
    <mesh_term>Mental Disorders</mesh_term>
    <mesh_term>Problem Behavior</mesh_term>
    <mesh_term>Attention Deficit and Disruptive Behavior Disorders</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Usual Care</title>
          <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
        </group>
        <group group_id="P2">
          <title>Usual Care Plus Assessment</title>
          <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="112"/>
                <participants group_id="P2" count="95"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>1 Month Follow up</title>
              <participants_list>
                <participants group_id="P1" count="67"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>3 Month Follow up</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>6 Month Follow up</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="79"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Never started ADHD medication</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>The population under study consists of children under age 18 who presented at 4 clinics in Northern California Kaiser Permanente for ADHD assessment. The study baseline population consists of 207 potentially eligible participants who enrolled and signed consent for the study.</population>
      <group_list>
        <group group_id="B1">
          <title>Usual Care</title>
          <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
        </group>
        <group group_id="B2">
          <title>Usual Care Plus Assessment</title>
          <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="112"/>
            <count group_id="B2" value="95"/>
            <count group_id="B3" value="207"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="112"/>
                    <count group_id="B2" value="95"/>
                    <count group_id="B3" value="207"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="112"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="207"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="112"/>
                    <count group_id="B2" value="95"/>
                    <count group_id="B3" value="207"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.5" spread="1.9"/>
                    <measurement group_id="B2" value="8.5" spread="1.9"/>
                    <measurement group_id="B3" value="8.5" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="112"/>
                    <count group_id="B2" value="95"/>
                    <count group_id="B3" value="207"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="30"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="82"/>
                    <measurement group_id="B2" value="68"/>
                    <measurement group_id="B3" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="112"/>
                    <count group_id="B2" value="95"/>
                    <count group_id="B3" value="207"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="112"/>
                    <measurement group_id="B2" value="95"/>
                    <measurement group_id="B3" value="207"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With 25% Reduction in SNAP Scores</title>
        <description>Outcome measure reported is the number of participants with at least one 25% reduction in SNAP between visits. In treatment of ADHD, the therapeutic dose is defined as a 25% reduction in SNAP IV score between consecutive clinic visits. SNAP is itemized rating scale (Swanson, Nolan, and Pelham-IV Questionnaire) designed to measure ADHD symptoms and severity on a 4 point scale. It is based on DSM IV criteria, and is designed to measure attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in children and young adults ages 6–18.</description>
        <time_frame>One month, 3 month and six month follow ups</time_frame>
        <population>Fifty eight (58) participants completed the study (i.e., had their 6 month follow up appointment) when the study was terminated.</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With 25% Reduction in SNAP Scores</title>
          <description>Outcome measure reported is the number of participants with at least one 25% reduction in SNAP between visits. In treatment of ADHD, the therapeutic dose is defined as a 25% reduction in SNAP IV score between consecutive clinic visits. SNAP is itemized rating scale (Swanson, Nolan, and Pelham-IV Questionnaire) designed to measure ADHD symptoms and severity on a 4 point scale. It is based on DSM IV criteria, and is designed to measure attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) symptoms in children and young adults ages 6–18.</description>
          <population>Fifty eight (58) participants completed the study (i.e., had their 6 month follow up appointment) when the study was terminated.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="29"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ADHD Symptomatology</title>
        <description>Outcomes reported are average SNAP IV scores at baseline and 6 monhts. ADHD symptomatology is measured by the Swanson, Nolan and Pelham Teacher and Parent Rating Scale (SNAP-IV), developed by James Swanson, Edith Nolan and William Pelham. We used the 18-item self-report inventory designed to measure attention deficit hyperactivity disorder (ADHD) symptoms in children and young adults. Each question measures the frequency of a variety of symptoms or behaviors.The subscales measure Inattention (9 items) and Hyperactivity/impulsivity (9 items), using 0-3 rating, 0=&quot;not at all&quot;, 1=&quot;just a little&quot;, 2=&quot;quite a bit&quot;, or 3=&quot;very much. Each 9-item subscale results in a score in range 0-27. The two subscale scores were averaged to create a single score for the 18-item SNAP.</description>
        <time_frame>6 months post baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>ADHD Symptomatology</title>
          <description>Outcomes reported are average SNAP IV scores at baseline and 6 monhts. ADHD symptomatology is measured by the Swanson, Nolan and Pelham Teacher and Parent Rating Scale (SNAP-IV), developed by James Swanson, Edith Nolan and William Pelham. We used the 18-item self-report inventory designed to measure attention deficit hyperactivity disorder (ADHD) symptoms in children and young adults. Each question measures the frequency of a variety of symptoms or behaviors.The subscales measure Inattention (9 items) and Hyperactivity/impulsivity (9 items), using 0-3 rating, 0=&quot;not at all&quot;, 1=&quot;just a little&quot;, 2=&quot;quite a bit&quot;, or 3=&quot;very much. Each 9-item subscale results in a score in range 0-27. The two subscale scores were averaged to create a single score for the 18-item SNAP.</description>
          <units>Score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Average SNAP score at baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.4" spread="4.8"/>
                    <measurement group_id="O2" value="15.0" spread="4.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Average SNAP score at 6 months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.0" spread="5.6"/>
                    <measurement group_id="O2" value="8.6" spread="5.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Academic Performance</title>
        <description>Academic performance will be measured by student report cards, and converted to a standardized scale</description>
        <time_frame>Baseline and Six Months</time_frame>
        <population>Academic performance was not measured, as there were a very low number of report cards collected (11 of 25 in Quotient arm and 16 of 33 in UC arm).</population>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>Academic Performance</title>
          <description>Academic performance will be measured by student report cards, and converted to a standardized scale</description>
          <population>Academic performance was not measured, as there were a very low number of report cards collected (11 of 25 in Quotient arm and 16 of 33 in UC arm).</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Persistence in Care</title>
        <description>Update: Outcome measure reported is the # of participants who attended all study follow-up visits.
Use of pediatric health care services</description>
        <time_frame>Baseline to Six Months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>Persistence in Care</title>
          <description>Update: Outcome measure reported is the # of participants who attended all study follow-up visits.
Use of pediatric health care services</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30"/>
                    <measurement group_id="O2" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Medication Adherence</title>
        <description>Update: Outcome reported is number of participants taking medication as prescribed at all study follow up visits.
Sustained use of ADHD medication</description>
        <time_frame>Baseline to six months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>Medication Adherence</title>
          <description>Update: Outcome reported is number of participants taking medication as prescribed at all study follow up visits.
Sustained use of ADHD medication</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Satisfaction With Care</title>
        <description>Update: Outcome measure reported is number of participants who responded &quot;very satisfied&quot; with their ADHD care on 5-point Likert scale.
Likert scale single item measure of how satisfied the pediatric patient's parent was with care received</description>
        <time_frame>Six months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction With Care</title>
          <description>Update: Outcome measure reported is number of participants who responded &quot;very satisfied&quot; with their ADHD care on 5-point Likert scale.
Likert scale single item measure of how satisfied the pediatric patient's parent was with care received</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Other Health Services Use</title>
        <description>Update: Outcome measure reported is number of psychiatric and ED visits during the 6 month follow up period.
Use of healthcare services outside of pediatrics, including the emergency room and psychiatric services.</description>
        <time_frame>Baseline to six months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Usual Care</title>
            <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
          </group>
          <group group_id="O2">
            <title>Usual Care Plus Assessment</title>
            <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
          </group>
        </group_list>
        <measure>
          <title>Other Health Services Use</title>
          <description>Update: Outcome measure reported is number of psychiatric and ED visits during the 6 month follow up period.
Use of healthcare services outside of pediatrics, including the emergency room and psychiatric services.</description>
          <units>visits</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="25"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Number of psych visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Number of ED visits</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months (from baseline to 6 month follow up)</time_frame>
      <desc>Adverse events were assessed via periodic chart reviews of study participants..</desc>
      <group_list>
        <group group_id="E1">
          <title>Usual Care</title>
          <description>Usual clinic ADHD care
Usual Clinic ADHD Care: Usual ADHD care as provided by the clinic</description>
        </group>
        <group group_id="E2">
          <title>Usual Care Plus Assessment</title>
          <description>Usual clinic ADHD care plus the Quotient®
Quotient®: Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="112"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="112"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Ashthma</sub_title>
                <description>Through chart review, it was discovered one patient was hospitalized due to severe asthma attack. Child has history of asthma, and this episode was likely triggered by URI. Was deemed by DSMB to not be related to the study.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="112"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="95"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="112"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="112"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Monique Does, Project manager</name_or_title>
      <organization>Kaiser Permanente Division of Research</organization>
      <phone>510-891-3612</phone>
      <email>monique.does@kp.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

